TK1 and neoplasm: However, the development by us of new generations of chicken polyclonal (IgY) [12] and mouse monoclonal anti-TK1 antibodies [13] extended the clinical use of TK1 to almost all types of solid human tumours, for both serum [12,14–27] and immunohistology [12,13,28] analysis.